Articles with "baseline risk" as a keyword



Photo from wikipedia

Fracture and Bone Mineral Density Response by Baseline Risk in Patients Treated With Abaloparatide Followed by Alendronate: Results From the Phase 3 ACTIVExtend Trial

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of Bone and Mineral Research"

DOI: 10.1002/jbmr.3848

Abstract: In the randomized, placebo‐controlled, double‐blind phase 3 ACTIVE study (NCT01343004), 18 months of abaloparatide 80 μg daily (subcutaneous injection) in postmenopausal women at risk of osteoporotic fracture significantly reduced the risk of vertebral, nonvertebral, clinical, and major… read more here.

Keywords: risk; bone mineral; fracture; baseline risk ... See more keywords
Photo from wikipedia

Baseline risk characterization of early versus later adopters of long‐acting paliperidone palmitate formulations

Sign Up to like & get
recommendations!
Published in 2022 at "Neuropsychopharmacology Reports"

DOI: 10.1002/npr2.12260

Abstract: Early Post‐Marketing Phase Vigilance (EPPV) is a unique system that encourages reporting of serious adverse reactions for medications newly introduced to Japan. When a once‐monthly paliperidone palmitate formulation (PP1M) was introduced in Japan in 2013,… read more here.

Keywords: baseline risk; paliperidone palmitate; mortality; risk ... See more keywords
Photo from wikipedia

Differences in baseline risk estimated by physicians and patients with early breast cancer.

Sign Up to like & get
recommendations!
Published in 2021 at "Japanese journal of clinical oncology"

DOI: 10.1093/jjco/hyab152

Abstract: BACKGROUND Physicians recommend adjuvant therapy to patients based on baseline risk. A common recognition for baseline risk between patients and physicians is critical for successful adjuvant therapy. We prospectively investigated the differences in estimated baseline… read more here.

Keywords: risk; differences estimated; estimated baseline; baseline risk ... See more keywords
Photo from wikipedia

Statins for the primary prevention of cardiovascular disease: an overview of systematic reviews

Sign Up to like & get
recommendations!
Published in 2019 at "BMJ Open"

DOI: 10.1136/bmjopen-2018-023085

Abstract: Objective To synthesise evidence from exclusively primary prevention data on the effectiveness of statins for prevention of cardiovascular disease (CVD), including stroke, and outcomes stratified by baseline risk and gender. Design Overview of systematic reviews… read more here.

Keywords: risk; baseline risk; systematic reviews; primary prevention ... See more keywords